Loading...
Emerging role of multikinase inhibitors for refractory thyroid cancer
Thyroid cancer incidence continues to increase, remaining the most common endocrine malignancy. The need for effective systemic therapies combined with high incidence of driver mutations and overexpression of molecular pathways make refractory thyroid cancer an ideal candidate for treatment with nov...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421474/ https://ncbi.nlm.nih.gov/pubmed/22904617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S24465 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|